Insufficient scRNA-seq data for expression of C20orf173 at single-cell level.
Insufficient scRNA-seq data for expression of C20orf173 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 42% | 0.93 | 102 / 241 | 0% | 0 | 0 / 0 |
| brain | 40% | 1.00 | 1044 / 2642 | 0% | 0 | 0 / 705 |
| prostate | 35% | 1.64 | 86 / 245 | 0% | 0 | 0 / 502 |
| ovary | 30% | 0.56 | 54 / 180 | 0% | 0.00 | 1 / 430 |
| adrenal gland | 28% | 0.49 | 72 / 258 | 0% | 0 | 0 / 230 |
| stomach | 25% | 0.46 | 89 / 359 | 1% | 0.01 | 3 / 286 |
| thymus | 26% | 0.66 | 167 / 653 | 0% | 0 | 0 / 605 |
| intestine | 25% | 0.47 | 242 / 966 | 0% | 0.01 | 2 / 527 |
| uterus | 25% | 0.46 | 42 / 170 | 0% | 0 | 0 / 459 |
| lung | 24% | 0.43 | 136 / 578 | 0% | 0.01 | 2 / 1155 |
| skin | 23% | 0.48 | 425 / 1809 | 0% | 0 | 0 / 472 |
| esophagus | 21% | 0.49 | 306 / 1445 | 1% | 0.02 | 1 / 183 |
| muscle | 21% | 0.58 | 166 / 803 | 0% | 0 | 0 / 0 |
| breast | 20% | 0.89 | 93 / 459 | 0% | 0.00 | 2 / 1118 |
| adipose | 20% | 0.35 | 241 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 20% | 0.33 | 266 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 20% | 0.33 | 64 / 328 | 0% | 0 | 0 / 178 |
| kidney | 19% | 0.33 | 17 / 89 | 0% | 0.01 | 3 / 901 |
| bladder | 19% | 0.38 | 4 / 21 | 0% | 0 | 0 / 504 |
| liver | 19% | 0.37 | 42 / 226 | 0% | 0 | 0 / 406 |
| peripheral blood | 17% | 0.27 | 160 / 929 | 0% | 0 | 0 / 0 |
| heart | 16% | 0.26 | 139 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0097503 | Biological process | sialylation |
| GO_0010706 | Biological process | ganglioside biosynthetic process via lactosylceramide |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0003836 | Molecular function | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity |
| Gene name | C20orf173 |
| Protein name | Chromosome 20 open reading frame 173 Uncharacterized protein C20orf173 |
| Synonyms | RP3-477O4.9-002 RP3-477O4.9-003 |
| Description | |
| Accessions | Q4VXR9 Q96LM9 ENST00000424444.1 ENST00000246199.5 [Q96LM9-1] ENST00000374345.8 [Q96LM9-2] Q4VXS0 ENST00000444723.3 [Q96LM9-2] |